全球蛋白質定序市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計蛋白質定序市場將從 2025 年的 20.6 億美元成長到 2034 年的 29.4 億美元，2026 年至 2034 年的複合年成長率為 4.04%。

隨著蛋白質體學在藥物發現、生物標記鑑定和精準醫療中發揮核心作用，蛋白質定序市場正迅速成長。質譜技術的進步、自動化Edman分解法以及用於N端和C端定序的新型化學技術的出現，正在拓展其應用範圍。藥物研發、臨床蛋白質體學和生物製藥品管等領域的需求推動了市場成長，在這些領域中，識別轉譯後修飾和序列變異至關重要。蛋白質體學研究經費的增加以及合約研究服務的興起，正在加速市場擴大。

關鍵促進因素包括蛋白質組學和基因組學的整合、生物製藥表徵領域投資的增加以及生物製造中對品管日益成長的需求。通量、靈敏度和資訊管線的改進正在降低每個樣本的處理時間和成本，從而促進其在研究和法規環境中的更廣泛應用。新興企業和成熟的儀器製造商正在投資開發結合定序和功能分析的工作流程，以提高其在轉化研究中的市場應用價值。

未來前景光明。單分子和高通量定序方法的持續創新、資訊處理技術的進步以及單樣本成本的降低將擴大其應用範圍。臨床蛋白質體學和蛋白質生物標記的監管核准預計將打開診斷市場。儀器供應商、軟體供應商和服務實驗室之間的合作將加速技術的應用，尤其是在精準癌症治療和生物製藥研發領域。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球蛋白質定序市場：依產品與服務分類

• 市場分析、洞察與預測
• 蛋白質定序產品
• 蛋白質定序服務

第5章 全球蛋白質定序市場：依應用領域分類

• 市場分析、洞察與預測
• 生物製藥
• 基因工程
• 其他

第6章 全球蛋白質定序市場：依最終用途分類

• 市場分析、洞察與預測
• 學術機構與研究中心
• 製藥和生物技術公司
• 其他

第7章 全球蛋白質定序市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Shimadzu Corporation
  • Agilent Technologies Inc
  • Rapid Novor Inc
  • Charles River Laboratories
  • Proteome Factory AG
  • Selvita
  • Bioinformatics Solutions Inc
  • Creative Proteomics
  • Alphalyse

The Protein Sequencing Market size is expected to reach USD 2.94 Billion in 2034 from USD 2.06 Billion (2025) growing at a CAGR of 4.04% during 2026-2034.

The protein sequencing market is growing rapidly as proteomics becomes central to drug discovery, biomarker identification, and precision medicine. Advances in mass spectrometry, Edman degradation automation, and novel chemistry for N- and C-terminal sequencing expand capabilities. Demand is driven by pharmaceutical R&D, clinical proteomics, and biopharma quality control where identification of post-translational modifications and sequence variants is critical. Increasing funding for proteomics and the rise of contract research services amplify market expansion.

Drivers include integration of proteomics with genomics, rising investment in biologics characterization, and growing demand for quality control in biomanufacturing. Improved throughput, sensitivity, and informatics pipelines reduce time and cost per sample, enabling broader adoption in both research and regulated environments. Startups and established instrument makers invest in workflows that couple sequencing with functional assays, increasing the market's applicability in translational studies.

Looking ahead, the market's prospects are strong: continued innovation in single-molecule and high-throughput sequencing methods, better informatics, and lower per-sample costs will expand use cases. Clinical proteomics and regulatory acceptance of protein biomarkers could open diagnostic markets. Collaboration between instrument vendors, software providers, and service labs will accelerate adoption, especially in precision oncology and biologic drug development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Protein Sequencing Products
• Protein Sequencing Services

By Application

• Bio-therapeutics
• Genetic Engineering
• Others

By End Use

• Academic Institutes & Research Centers
• Pharmaceutical & Biotechnology Companies
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Shimadzu Corporation, Agilent Technologies Inc, Rapid Novor Inc, Charles River Laboratories, Proteome Factory AG, Selvita, Bioinformatics Solutions Inc, Creative Proteomics, Alphalyse
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PROTEIN SEQUENCING MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Protein Sequencing Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Protein Sequencing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PROTEIN SEQUENCING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Bio-therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Genetic Engineering Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PROTEIN SEQUENCING MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Academic Institutes & Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PROTEIN SEQUENCING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product & Service
  • 7.2.2 By Application
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product & Service
  • 7.3.2 By Application
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product & Service
  • 7.4.2 By Application
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product & Service
  • 7.5.2 By Application
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product & Service
  • 7.6.2 By Application
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PROTEIN SEQUENCING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Shimadzu Corporation
  • 9.2.3 Agilent Technologies Inc
  • 9.2.4 Rapid Novor Inc
  • 9.2.5 Charles River Laboratories
  • 9.2.6 Proteome Factory AG
  • 9.2.7 Selvita
  • 9.2.8 Bioinformatics Solutions Inc
  • 9.2.9 Creative Proteomics
  • 9.2.10 Alphalyse